These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22823914)

  • 21. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.
    Bajaj JS; O'Leary JG; Tandon P; Wong F; Kamath PS; Biggins SW; Garcia-Tsao G; Lai J; Fallon MB; Thuluvath PJ; Vargas HE; Maliakkal B; Subramanian RM; Thacker LR; Reddy KR
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1518-1527. PubMed ID: 31032966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Duphalac in combination therapy of patients with hepatic cirrhosis].
    Anokhina GA; Chervak IN; Lopukh IIa
    Lik Sprava; 2001; (3):150-2. PubMed ID: 11560007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 25. Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
    Chow KW; Ibrahim BM; Yum JJ; Dang A; Dang L; Chen KT; Jackson NJ; Saab S
    Dig Dis Sci; 2023 Jun; 68(6):2389-2397. PubMed ID: 37119376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Tapper EB
    JAMA Intern Med; 2015 May; 175(5):868. PubMed ID: 25938321
    [No Abstract]   [Full Text] [Related]  

  • 27. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Cutler T; Mints G
    JAMA Intern Med; 2015 May; 175(5):867-8. PubMed ID: 25938320
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyethylene Glycol Versus Lactulose for Hepatic Encephalopathy: Do We Have a Clear Winner?
    Giri S
    J Clin Gastroenterol; 2022 Feb; 56(2):192. PubMed ID: 35104256
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Frenette CT; Levy C; Saab S
    Dig Dis Sci; 2022 Jun; 67(6):1994-2004. PubMed ID: 34169435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
    Rahimi RS; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2015 May; 175(5):868-9. PubMed ID: 25938322
    [No Abstract]   [Full Text] [Related]  

  • 31. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 32. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Gastroenterol Nurs; 2019; 42(3):E3-E4. PubMed ID: 31145254
    [No Abstract]   [Full Text] [Related]  

  • 33. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
    Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.
    Loguercio C; Abbiati R; Rinaldi M; Romano A; Del Vecchio Blanco C; Coltorti M
    J Hepatol; 1995 Jul; 23(1):39-46. PubMed ID: 8530808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 36. Polyethylene glycol for hepatic encephalopathy: a new solution to purge an old problem?
    Doran AE; Shah NL
    JAMA Intern Med; 2014 Nov; 174(11):1734-5. PubMed ID: 25244573
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
    Doffoël M; Vetter D
    Gastroenterol Clin Biol; 1994; 18(12):1055-6. PubMed ID: 7750676
    [No Abstract]   [Full Text] [Related]  

  • 38. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2011; 17(2):138-41. PubMed ID: 21372353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durability of rifaximin response in hepatic encephalopathy.
    Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
    J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP.
    Flamm SL
    J Fam Pract; 2017 Apr; 66(4 Suppl):S34-S39. PubMed ID: 28375406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.